Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03511937 · ClinicalTrials.gov registry record · NA
Impact of Sugar-Sweetened Beverage Health Warnings
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT03511937 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 400 participants.
The verdict
NCT03511937, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
Consumption of sugar-sweetened beverages (SSBs) like sodas, sports drinks, and fruit drinks remains a pressing public health concern in the United States. Consumption of SSBs remains well above recommended levels, and has been linked to obesity, diabetes, and cardiovascular disease. In response, policymakers across the U.S. have proposed requiring warning messages on SSB containers to inform the public and reduce consumption to healthier levels. While online studies find that such warnings reduce intentions to purchase SSBs, no studies have yet examined the impact of warnings on actual consumer behavior. The purpose of this randomized trial is to determine whether health warnings on sugar-sweetened beverages are more effective than control labels at reducing purchases of sugar-sweetened beverages. The trial will take place in a mock convenience store. Participants will be randomly assigned to a health warnings arm in which all sugar-sweetened beverages in the store are labeled with a health warning, or to a control arm in which all sugar-sweetened beverages in the store are labeled with a neutral label. Participants will select items to purchase with cash, and purchases will be compared across trial arms.
Interventions
- BEHAVIORAL Sugar-Sweetened Beverage Health Warning Label
- OTHER Neutral Label
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2018-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03511937
The ClinicalTrials.gov registry entry for NCT03511937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sugar-Sweetened Beverage Health Warning Label is the first listed.
NCT03511937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03511937 about?
NCT03511937 is a clinical study titled "Impact of Sugar-Sweetened Beverage Health Warnings". Consumption of sugar-sweetened beverages (SSBs) like sodas, sports drinks, and fruit drinks remains a pressing public health concern in the United States. Consumption of SSBs remains well above recommended levels, and has been linked to obesity, diabetes, and cardiovascular disease. In response, pol...
What is the current status of trial NCT03511937?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2018-05-11. Estimated completion is 2018-09-19.
What interventions are being tested in trial NCT03511937?
The interventions under investigation include: Sugar-Sweetened Beverage Health Warning Label (BEHAVIORAL), Neutral Label (OTHER).
Who is sponsoring clinical trial NCT03511937?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.